17 results on '"Fukuo Y"'
Search Results
2. Acute-Stage Mental Health Symptoms by Natural Disaster Type: Consultations of Disaster Psychiatric Assistance Teams (DPATs) in Japan.
- Author
-
Takagi Y, Takahashi S, Fukuo Y, Arai T, and Tachikawa H
- Subjects
- Humans, Japan epidemiology, Mental Health, Referral and Consultation, Disasters, Earthquakes, Mental Disorders epidemiology
- Abstract
This study analyzed the support activities that the Disaster Psychiatric Assistance Team (DPAT) in Japan provided following four previous disasters (a volcanic eruption, a mudslide, a flood, and an earthquake) to identify links between the disaster type and the characteristics of acute stage mental disorders observed. Using Disaster Mental Health Information Support System database records of consultations with patients supported by the DPAT during the survey period from 2013 (when DPAT was launched) to 2016, we performed cross-tabulations and investigated significant differences using chi-squared tests. For expected values less than 5, Fisher's exact test was performed. Frequently occurring acute-stage symptoms after a disaster include anxiety, sleep problems, mood and affect, and physical symptoms. The affected population characteristics, victim attributes, severity of damage sustained, and evacuation status were the chief factors that influenced acute-stage mental health symptoms. The psychiatric symptoms detected in our study together with the results of diagnoses are important for determining the types of early interventions needed during the acute stage of a disaster. By sharing baseline mental health information, together with disaster-related characteristics highlighted in this study, mental health providers are better able to predict future possible mental disorders and symptoms.
- Published
- 2021
- Full Text
- View/download PDF
3. Acute Mental Health Needs Duration during Major Disasters: A Phenomenological Experience of Disaster Psychiatric Assistance Teams (DPATs) in Japan.
- Author
-
Takahashi S, Takagi Y, Fukuo Y, Arai T, Watari M, and Tachikawa H
- Subjects
- Disaster Planning, Female, Humans, Japan, Male, Referral and Consultation, Disasters, Earthquakes, Mental Health, Mental Health Services statistics & numerical data, Patient Acceptance of Health Care statistics & numerical data
- Abstract
Background: How long acute mental health needs continue after the disaster are problems which must be addressed in the treatment of victims. The aim of this study is to determine victims' needs by examining activity data from Disaster Psychiatric Assistance Teams (DPATs) in Japan., Methods: Data from four disasters were extracted from the disaster mental health information support system (DMHISS) database, and the transition of the number of consultations and the activity period were examined., Results: Common to all four disasters, the number of consultations increased rapidly from 0-2 days, reaching a peak within about a week. The partial correlation coefficient between the number of days of activity and the maximum number of victims showed significance. The number of victims and days of activity can be used to obtain a regression curve., Conclusions: This is the first report to reveal that mental health needs are the greatest in the hyper-acute stage, and the need for consultation and the duration of needs depends on the number of victims., Competing Interests: The authors declare no conflict of interest.
- Published
- 2020
- Full Text
- View/download PDF
4. No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia.
- Author
-
Kishi T, Fukuo Y, Moriwaki M, Iwata N, Hori H, Yoshimura R, Katsuki A, Ikenouchi-Sugita A, Atake K, Umene-Nakano W, Nakamura J, Kaneda Y, and Fujita K
- Subjects
- Adult, Cognition Disorders physiopathology, Cross-Sectional Studies, Female, Genotype, Humans, Japan, Male, Neuropsychological Tests, Polymorphism, Single Nucleotide, Reverse Transcriptase Polymerase Chain Reaction, Asian People genetics, Brain-Derived Neurotrophic Factor genetics, Cognition physiology, Cognition Disorders genetics, Schizophrenia genetics
- Published
- 2014
- Full Text
- View/download PDF
5. [The revised system of hospitalization for medical care and protection].
- Author
-
Fukuo Y
- Subjects
- Humans, Informed Consent, Japan, Legal Guardians, Patient Care, Patient Discharge, Hospitalization legislation & jurisprudence, Mental Disorders therapy
- Abstract
The Act to Partially Amend the Act on Mental Health and Welfare for the Mentally Disabled was passed on June 13, 2013. Major amendments regarding hospitalization for medical care and protection include the points listed below. The guardianship system will be abolished. Consent by a guardian will no longer be required in the case of hospitalization for medical care and protection. In the case of hospitalization for medical care and protection, the administrators of the psychiatric hospital are required to obtain the consent of one of the following persons: spouse, person with parental authority, person responsible for support, legal custodian, or curator. If no qualified person is available, consent must be obtained from the mayor, etc. of the municipality. The following three obligations are imposed on psychiatric hospital administrators. (1) Assignment of a person, such as a psychiatric social worker, to provide guidance and counseling to patients hospitalized for medical care and protection regarding their postdischarge living environment. (2) Collaboration with community support entities that consult with and provide information as necessary to the person hospitalized, their spouse, a person with parental authority, a person responsible for support, or their legal custodian or curator. (3) Organizational improvements to promote hospital discharge. With regard to requests for discharge, the revised law stipulates that, in addition to the person hospitalized with a mental disorder, others who may file a request for discharge with the psychiatric review board include: the person's spouse, a person with parental authority, a person responsible for support, or their legal custodian or curator. If none of the above persons are available, or if none of them are able to express their wishes, the mayor, etc. of the municipality having jurisdiction over the place of residence of the person hospitalized may request a discharge. In order to promote transition to life in the community by persons with mental disorders, efforts will be made to enhance psychiatric care for them, with guidelines to be developed to ensure the provision of medical care to persons with mental disorders. The revised law clarifies that members of psychiatric review boards shall be "persons with expert knowledge and experience pertaining to the health and/or welfare of persons with mental disorders." Provision is made for a review of conditions related to implementation of the revised law approximately three years after it takes effect, with measures to be taken as necessary based on results of the review. The main focus of this presentation will be the revisions to the system of hospitalization for medical care and protection, and the deletion of provisions relating to the system of guardianship.
- Published
- 2014
6. Relationship between nicotine dependence and the endophenotype-related trait of cognitive function but not acoustic startle reponses in Japanese patients with schizophrenia.
- Author
-
Kishi T, Fukuo Y, Okochi T, Kawashima K, Moriwaki M, Furukawa O, Musso GM, Fujita K, Correll CU, and Iwata N
- Subjects
- Adult, Aged, Case-Control Studies, Endophenotypes, Executive Function physiology, Female, Humans, Japan, Linear Models, Male, Middle Aged, Polymorphism, Single Nucleotide, Reflex, Startle, Severity of Illness Index, Tobacco Use Disorder genetics, Cognition, Receptors, Nicotinic genetics, Schizophrenia physiopathology, Tobacco Use Disorder physiopathology
- Abstract
Objectives: We investigated whether nicotine dependence affects these endophenotypes in Japanese schizophrenia patients and whether alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (alpha4 subunit of the nAChR gene (CHRNA4)/beta2 subunit of the nAChR gene (CHRNB2)) were associated with nicotine dependence in patients (n = 100) and healthy controls (n = 107)., Methods: First, in patients, we evaluated cognitive function, using the Brief Assessment of Cognition in Schizophrenia, and acoustic startle responses. Second, we evaluated the severity of nicotine dependence, using the Tobacco Dependence Screener, the Fagerström Test for Nicotine Dependence, and the Brinkman index in current smokers in both groups. Third, we evaluated the relationship between acoustic startle responses, cognitive function, and severity of nicotine dependence. Finally, using 12 tagging single-nucleotide polymorphisms in each the CHRNA4/CHRNB2, we used multiple linear regression analysis to examine the association between nicotine dependence measures and each selected single-nucleotide polymorphism., Results: The presence and severity of nicotine dependence were associated with verbal memory and executive function in schizophrenia patients. However, nicotine dependence was not correlated with any acoustic startle response. In addition, rs755203 and rs1044397 in CHRNA4 were associated with nicotine dependence in healthy controls., Conclusions: Nicotine dependence might influence the level of verbal memory and executive function in schizophrenia patients. In addition, rs755203 and rs1044397 in CHRNA4 might play a role in the pathophysiology of nicotine dependence in healthy controls in the Japanese population., (Copyright © 2013 John Wiley & Sons, Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
7. An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders.
- Author
-
Matsunaga S, Ikeda M, Kishi T, Fukuo Y, Aleksic B, Yoshimura R, Okochi T, Yamanouchi Y, Kinoshita Y, Kawashima K, Umene-Nakano W, Inada T, Kunugi H, Kato T, Yoshikawa T, Ujike H, Nakamura J, Ozaki N, Kitajima T, and Iwata N
- Subjects
- Female, Genetic Markers genetics, Humans, Japan epidemiology, Male, Middle Aged, Prevalence, Risk Factors, Casein Kinase 1 epsilon genetics, Casein Kinase Idelta genetics, Genetic Predisposition to Disease epidemiology, Genetic Predisposition to Disease genetics, Mental Disorders epidemiology, Mental Disorders genetics, Polymorphism, Single Nucleotide genetics
- Abstract
Disturbances of the circadian rhythm are involved in the pathophysiology of bipolar disorder (BD), schizophrenia (SCZ) and major depressive disorder (MDD). Specifically, because clock gene dysfunction is good candidate for enhancing the susceptibility to these psychiatric disorders, we selected two circadian rhythm-related genes (CSNK1D and CSNK1E) and investigated genetic associations of the genes with these three disorders. None of the SNPs showed a significant association with MDD, but a SNP (rs2075984) in CSNK1E and SNP (rs6502097) in CSNK1D were associated with SCZ (P=0.0091, uncorrected) and BD (P=0.030, uncorrected), respectively. To confirm these findings, we analyzed an independent dataset (maximum N=3815) but found a lack of association (P=0.63 for rs2075984 and P=0.61 for rs6502097). The final meta-analysis showed no association between these SNPs with SCZ (P=0.21) and BD (P=0.53). These results do not support that genetic variation in CSNK1D and CSNK1E is a susceptibility factor for major psychiatric disorders in the Japanese population., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
8. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility.
- Author
-
Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, Shiino T, Okochi T, Fukuo Y, Ujike H, Suzuki M, Inada T, Hashimoto R, Takeda M, Kaibuchi K, Iwata N, and Ozaki N
- Subjects
- Adult, Exons genetics, Female, Genetic Predisposition to Disease, Genotype, Humans, Japan epidemiology, Male, Middle Aged, Mutation, Missense genetics, Risk Factors, Schizophrenia epidemiology, Genome-Wide Association Study methods, Guanine Nucleotide Exchange Factors genetics, Protein Serine-Threonine Kinases genetics, Receptor, EphB1 genetics, Schizophrenia genetics
- Abstract
Background: Our genome-wide association study of schizophrenia found association signals at the Kalirin gene (KALRN) and EPH receptor B1 gene (EPHB1) in a Japanese population. The importance of these synaptogenic pathway genes in schizophrenia is gaining independent supports. Although there has been growing interest in rare (<1%) missense mutations as potential contributors to the unexplained heritability of schizophrenia, there are no population-based studies targeting rare (<1%) coding mutations with a larger effect size (eg, OR >1.5) in KALRN or EPHB1., Methods and Results: The present study design consisted of 3 phases. At the discovery phase, we conducted resequencing analyses for all exon regions of KALRN and EPHB1 using a DNA microarray-based method. Seventeen rare (<1%) missense mutations were discovered in the first sample set (320 schizophrenic patients). After the prioritization phase based on frequencies in the second sample set (729 cases and 562 controls), we performed association analyses for each selected mutation using the third sample set (1511 cases and 1517 controls), along with a combined association analysis across all selected mutations. In KALRN, we detected a significant association between schizophrenia and P2255T (OR = 2.09, corrected P = .048, 1 tailed); this was supported in the combined association analysis (OR = 2.07, corrected P = .006, 1 tailed). We found no evidence of association of EPHB1 with schizophrenia. In silico analysis indicated the functional relevance of these rare missense mutations., Conclusion: We provide evidence that multiple rare (<1%) missense mutations in KALRN may be genetic risk factors for schizophrenia.
- Published
- 2012
- Full Text
- View/download PDF
9. Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysis.
- Author
-
Kishi T, Fukuo Y, Okochi T, Kawashima K, Kitajima T, Inada T, Ozaki N, Musso GM, Kane JM, Correll CU, and Iwata N
- Subjects
- Adult, Case-Control Studies, Female, Genetic Predisposition to Disease, Genotype, Haplotypes, Humans, Japan, Male, Middle Aged, Polymorphism, Single Nucleotide, Receptors, Serotonin genetics, Schizophrenia genetics
- Abstract
Objectives: Several lines of evidence suggest that genetic alterations in serotonin 6 (5-HT6) receptors might be associated with the pathophysiology of schizophrenia. We sought to assess the relationship between genotype alterations in 5-HT6 receptors and schizophrenia both in a case-control study and a meta-analysis., Methods: We conducted an association study of the 5-HT6 receptor gene (HTR6) in Japanese patients with schizophrenia (n = 836) and controls (n = 857). Five tagging single-nucleotide polymorphisms (SNPs), including rs1805054 (C267T) in HTR6, were selected. In addition, we carried out a meta-analysis between rs1805054, which has been examined in other studies, and schizophrenia, searching PubMed through August 2011., Results: There were no significant associations between the tagging SNPs in HTR6 and schizophrenia in any of the genotype models in both the simple and the multiple logistic regression analyses correcting for potential confounds. Similarly, no significant association was found in the all-marker haplotype multiple logistic regression analysis (p = 0.491). Moreover, in the meta-analysis of rs1805054, drawing data from five studies, including our own (schizophrenia patients = 1366, controls = 1376), rs1805054 was also not associated with schizophrenia., Conclusions: Our results indicate that tagging SNPs in HTR6 may not play a role in the pathophysiology of schizophrenia.
- Published
- 2012
- Full Text
- View/download PDF
10. The CLOCK gene and mood disorders: a case-control study and meta-analysis.
- Author
-
Kishi T, Yoshimura R, Fukuo Y, Kitajima T, Okochi T, Matsunaga S, Inada T, Kunugi H, Kato T, Yoshikawa T, Ujike H, Umene-Nakano W, Nakamura J, Ozaki N, Serretti A, Correll CU, and Iwata N
- Subjects
- Adult, Aged, Asian People genetics, Bipolar Disorder genetics, Case-Control Studies, Depressive Disorder, Major genetics, Female, Genetic Association Studies, Humans, Japan, Male, Middle Aged, Polymorphism, Single Nucleotide, RNA, Messenger genetics, CLOCK Proteins genetics, Mood Disorders genetics
- Abstract
The clock gene (CLOCK) is considered to be a good candidate gene for the pathophysiology of mood disorders, including bipolar disorder (BP) and major depressive disorder (MDD). rs1801260 (T3111C) has been detected at position 3111 in the CLOCK mRNA 3' untranslated region, and was reported to be associated with a substantial delay in preferred timing for activity and sleep in a human study. As for function, rs1801260 has been speculated to affect mRNA. Therefore, the authors investigated the association between the three tagging single-nucleotide polymorphisms (SNPs) (rs3736544, rs1801260, and rs3749474) in CLOCK and risk of BP (n=867) and MDD (n=139) compared to controls (n=889) in the Japanese population. In addition, we also performed an updated meta-analysis of nine published, genetic association studies investigating the relationship between rs1801260 and mood disorder risk, comprising 3321 mood disorders cases and 3574 controls. We did not detect any associations between tagging SNPs in CLOCK and BP or MDD in the allele, genotype, or haplotype analysis (global p(BP)=.605 and global p(MDD)=.211). Moreover, rs1801260 was also not associated with BP, MDD, or any mood disorders in the meta-analysis. In conclusion, these data suggest that CLOCK does not play a major role in the pathophysiology of mood disorders.
- Published
- 2011
- Full Text
- View/download PDF
11. No significant association between SIRT1 gene and methamphetamine-induced psychosis in the Japanese population.
- Author
-
Kishi T, Fukuo Y, Okochi T, Kitajima T, Ujike H, Inada T, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Correll CU, and Iwata N
- Subjects
- Adult, Asian People, Case-Control Studies, Databases, Genetic, Humans, Japan, Linkage Disequilibrium, Male, Middle Aged, Polymorphism, Single Nucleotide, Psychoses, Substance-Induced etiology, Young Adult, Central Nervous System Stimulants adverse effects, Methamphetamine adverse effects, Psychoses, Substance-Induced genetics, Sirtuin 1 genetics
- Abstract
Objectives: We previously showed that the sirtuin 1 gene (SIRT1 gene), one of the clock genes, was associated with schizophrenia in a Japanese patient population. Because the symptoms of methamphetamine (METH)-induced psychosis are similar to those of paranoid type schizophrenia and because not every METH user develops psychosis, it is conceivable that METH-induced psychosis and schizophrenia have common susceptibility genes. Therefore, we conducted an analysis of the association of SIRT1 gene with METH-induced psychosis, hypothesizing a significant relationship., Methods: This paper presents a case-control study of the SIRT1 gene in 515 Japanese individuals (197 with METH-induced psychosis and 318 age-matched and sex-matched controls) with four tagging single nucleotide polymorphisms (rs12778366, rs2273773, rs4746720, and rs10997875), selected a priori using the HapMap database., Results: rs10997875 (located in the 3' flanking region) was associated with METH-induced psychosis (unadjusted p(genotype) = 0.0203). However, these results became non-significant after Bonferroni correction (corrected p(genotype) = 0.0812). In the all-marker haplotype analysis, the SIRT1 gene was not associated with METH-induced psychosis (p = 0.146)., Conclusion: Our findings suggest that SIRT1 gene does not contribute to the development of METH-induced psychosis in the Japanese population. However, a replication study using larger samples should be conducted to obtain conclusive results., (Copyright © 2011 John Wiley & Sons, Ltd.)
- Published
- 2011
- Full Text
- View/download PDF
12. Genome-wide association study of schizophrenia in a Japanese population.
- Author
-
Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, Kushima I, Ito Y, Nakamura Y, Kishi T, Okumura T, Fukuo Y, Williams HJ, Hamshere ML, Ivanov D, Inada T, Suzuki M, Hashimoto R, Ujike H, Takeda M, Craddock N, Kaibuchi K, Owen MJ, Ozaki N, O'Donovan MC, and Iwata N
- Subjects
- Adult, Alleles, Asian People, Female, Follow-Up Studies, Gene Frequency, Genetic Markers, Genetic Predisposition to Disease, Genotype, Haplotypes, Humans, Japan epidemiology, Male, Middle Aged, Multifactorial Inheritance, Polymorphism, Single Nucleotide, Quality Control, Reverse Transcriptase Polymerase Chain Reaction, United Kingdom epidemiology, Genome-Wide Association Study, Schizophrenia epidemiology, Schizophrenia genetics
- Abstract
Background: Genome-wide association studies have detected a small number of weak but strongly supported schizophrenia risk alleles. Moreover, a substantial polygenic component to the disorder consisting of a large number of such alleles has been reported by the International Schizophrenia Consortium., Method: We report a Japanese genome-wide association study of schizophrenia comprising 575 cases and 564 controls. We attempted to replicate 97 markers, representing a nonredundant panel of markers derived mainly from the top 150 findings, in up to three data sets totaling 1990 cases and 5389 controls. We then attempted to replicate the observation of a polygenic component to the disorder in the Japanese and to determine whether this overlaps that seen in UK populations., Results: Single-locus analysis did not reveal genome-wide support for any locus in the genome-wide association study sample (best p = 6.2 × 10(-6)) or in the complete data set in which the best supported locus was SULT6B1 (rs11895771: p = 3.7 × 10(-5) in the meta-analysis). Of loci previously supported by genome-wide association studies, we obtained in the Japanese support for NOTCH4 (rs2071287: p(meta) = 5.1 × 10(-5)). Using the approach reported by the International Schizophrenia Consortium, we replicated the observation of a polygenic component to schizophrenia within the Japanese population (p = .005). Our trans Japan-UK analysis of schizophrenia also revealed a significant correlation (best p = 7.0 × 10(-5)) in the polygenic component across populations., Conclusions: These results indicate a shared polygenic risk of schizophrenia between Japanese and Caucasian samples, although we did not detect unequivocal evidence for a novel susceptibility gene for schizophrenia., (Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
13. SIRT1 gene is associated with major depressive disorder in the Japanese population.
- Author
-
Kishi T, Yoshimura R, Kitajima T, Okochi T, Okumura T, Tsunoka T, Yamanouchi Y, Kinoshita Y, Kawashima K, Fukuo Y, Naitoh H, Umene-Nakano W, Inada T, Nakamura J, Ozaki N, and Iwata N
- Subjects
- Alleles, Depressive Disorder, Major drug therapy, Female, Genetic Association Studies, Genotype, Haplotypes genetics, Humans, Japan, Male, Middle Aged, Polymorphism, Single Nucleotide genetics, Psychiatric Status Rating Scales, Selective Serotonin Reuptake Inhibitors therapeutic use, Treatment Outcome, Depressive Disorder, Major genetics, Sirtuin 1 genetics
- Abstract
Background: Many studies including our previous ones as to PROKR2 and CLOCK have suggested that circadian genes may be involved in the mechanisms of mood disorders and their treatment responses. Also several recent investigations have reported that SIRT1 plays an important role in the circadian system as conventional circadian clock genes, and also have some relation to dopaminergic metabolism. So we considered the SIRT1 gene to be a good candidate gene for the pathophysiology for MDD and SSRI responses in MDD, and conducted a case-control study using four tagging SNPs (450 MDD patients, including 261 patients treated by SSRIs and 766 controls)., Method: The MDD patients in this study had scores of 12 or higher on the 17 items of the Structured Interview Guide for Hamilton Rating Scale for Depression (SIGH-D). We defined a clinical response as a decrease of more than 50% in baseline SIGH-D within 8 weeks, and clinical remission as an SIGH-D score of less than 7 at 8 weeks. Marker-trait association analysis was used to evaluate allele and genotype association with the chi-square test, and haplotype association analysis was evaluated with a likelihood ratio test., Result: We found an association between rs10997875 in SIRT1 gene and MDD in the allele/genotype analysis. In addition, this significance of these associations survived Bonferroni correction. However, we did not find any association between SIRT1 gene and SSRI therapeutic response in MDD in the allele/genotype analysis or haplotype analysis., Limitations: A replication study using larger samples may be required for conclusive results, since our sample size was small., Conclusions: Our results suggest that rs10997875 in SIRT1 gene may play a role in the pathophysiology of MDD in the Japanese population., (Copyright 2010 Elsevier B.V. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
14. Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population.
- Author
-
Kishi T, Fukuo Y, Yoshimura R, Okochi T, Kitajima T, Naitoh H, Umene-Nakano W, Nakamura J, Ozaki N, and Iwata N
- Subjects
- Alleles, Asian People, Case-Control Studies, Depressive Disorder, Major genetics, Female, Genetic Association Studies, Genotype, Humans, Japan, Male, Psychiatric Status Rating Scales, Depressive Disorder, Major drug therapy, Polymorphism, Single Nucleotide, Receptors, Serotonin genetics, Selective Serotonin Reuptake Inhibitors therapeutic use
- Abstract
Objective: Several investigations have suggested that alterations in serotonin 6 (5-HT6) receptors might be associated with the pathophysiology of major depressive disorder (MDD), and that 5-HT6 receptors might be a therapeutic target for serotonin selective reuptake inhibitor (SSRI) in MDD. To evaluate the association between HTR6 and the efficacy of SSRI treatment in Japanese MDD patients, we conducted a case-control study in a Japanese population sample., Methods: We selected five tagging SNPs (rs6693503, rs1805054, rs4912138, rs3790757 and rs9659997), and performed an association analysis of HTR6 and the efficacy of SSRI treatment in 260 MDD patients., Results: We did not detect an association between tagging SNPs in HTR6 and the therapeutic response to SSRI in MDD in allele/genotype or haplotype analysis., Conclusions: HTR6 may not play an important role in the pathophysiology of SSRI response in the Japanese population. Because our sample was relatively small, statistical errors were possible in the results of our association analyses. To overcome these limitations, a replication study using a larger sample may be required for conclusive results., (Copyright 2010 John Wiley & Sons, Ltd.)
- Published
- 2010
- Full Text
- View/download PDF
15. Association analysis of SIGMAR1 with major depressive disorder and SSRI response.
- Author
-
Kishi T, Yoshimura R, Okochi T, Fukuo Y, Kitajima T, Okumura T, Tsunoka T, Kawashima K, Yamanouchi Y, Kinoshita Y, Umene-Nakano W, Naitoh H, Nakamura J, Ozaki N, and Iwata N
- Subjects
- Adult, Case-Control Studies, Female, Fluvoxamine therapeutic use, Genetic Association Studies, Genotype, Humans, Japan, Logistic Models, Male, Middle Aged, Phenotype, Psychiatric Status Rating Scales, Remission Induction, Sertraline therapeutic use, Time Factors, Treatment Outcome, Sigma-1 Receptor, Depressive Disorder, Major drug therapy, Depressive Disorder, Major genetics, Polymorphism, Single Nucleotide, Receptors, sigma genetics, Selective Serotonin Reuptake Inhibitors therapeutic use
- Abstract
Background: Several investigations have suggested the possible involvement of sigma 1 non-opioid intracellular receptor 1 (sigma 1 receptor) in the pathophysiology of major depressive disorder (MDD). Sigma 1 receptors are also one of the major pharmacological therapeutic targets of selective serotonin reuptake inhibitors (SSRIs). To evaluate the association of sigma 1 receptor gene (SIGMAR1) and MDD and SSRIs therapeutic response in MDD, we conducted a case-control study of Japanese samples (466 MDD patients, 516 controls and 208 MDD patients treated by fluvoxamine or sertraline)., Method: We defined a clinical response as a decrease of more than 50% in baseline the Structured Interview Guide for Hamilton Rating Scale for Depression (SIGH-D) within 8 weeks, and clinical remission as an SIGH-D score of less than 7 at 8 weeks. Therefore, we selected rs1800866 in SIGMAR1 for the following association analysis., Results: In the logistic regression analysis, we detected an association of the phenotypes (MDD or controls) with rs1800866 genotype. However, we did not detect an association between rs1800866 and SSRI therapeutic response in Japanese MDD. In addition, remission with SSRI was not associated with rs1800866. Also, we did not detect a novel polymorphism in SIGMAR1 when we performed a mutation search using MDD treated by SSRIs samples., Conclusion: Our results suggest that rs1800866 in SIGMAR1 may play a role in the pathophysiology of MDD in the Japanese population. Also, SIGMAR1 does not play a role in the therapeutic response to SSRI in Japanese MDD patients. However, because our sample was small, a replication study using another population and larger sample will be required for conclusive results., ((c) 2010. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
16. Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia.
- Author
-
Kishi T, Moriwaki M, Kitajima T, Kawashima K, Okochi T, Fukuo Y, Furukawa O, Naitoh H, Fujita K, and Iwata N
- Subjects
- Acoustic Stimulation, Adult, Aged, Aripiprazole, Asian People, Female, Humans, Japan, Male, Middle Aged, Olanzapine, Schizophrenia ethnology, Schizophrenia physiopathology, Schizophrenic Psychology, Treatment Outcome, Antipsychotic Agents therapeutic use, Benzodiazepines therapeutic use, Blinking drug effects, Piperazines therapeutic use, Quinolones therapeutic use, Reflex, Startle drug effects, Risperidone therapeutic use, Schizophrenia drug therapy
- Abstract
Background: Studies have also shown that differences in the kind of the antipsychotics influenced disruption of the sensorimotor gating system, including prepulse inhibition (PPI), acoustic startle reflex (ASR), and habituation (HAB). We investigated the influence on startle response in chronic schizophrenia in 20 patients with schizophrenia taking risperidone, 21 patients with schizophrenia taking olanzapine, and 20 patients with schizophrenia taking aripiprazole., Method: The patients who participated in this study were on maintenance therapy with only one antipsychotic drug for 4 months. We performed the test for the association between all PPI measures (ASR, HAB, and PPI at prepulse sound pressure intensities of 82, 86, and 90 dB) and each the risperidene, olanzapine, and aripiprazole groups, with analysis of covariance (ANCOVA; using age, duration of illness, and daily dose of the antipsychotic as covariates). Also, when significant difference was detected in ANCOVA, the differences of PPI measures between every pairs of two drug groups were tested as a post hoc analysis with the use of t test and Bonferroni's correction of multiple tests., Result: We found that PPI90 showed significant differences with ANCOVA among patients with schizophrenia taking each of the antipsychotics. When we performed a post hoc analysis for PPI90, the value was higher in the aripiprazole group than in the olanzapine group and higher in the risperidone group than in the olanzapine group., Conclusion: Aripiprazole and risperidone may improve PPI90. ASR, HAB, PPI82, and PPI86 were no different among the Japanese schizophrenic patient groups with different antipsychotics.
- Published
- 2010
- Full Text
- View/download PDF
17. Clinical features associated with the homozygous Trp64Arg mutation of the beta3-adrenergic receptor: no evidence for its association with obesity in Japanese.
- Author
-
Sun L, Ishibashi S, Osuga J, Harada K, Ohashi K, Gotoda T, Fukuo Y, Yazaki Y, and Yamada N
- Subjects
- Arginine, Blood Pressure, Body Mass Index, Cholesterol, LDL blood, Cohort Studies, Diabetes Mellitus, Type 2, Electrocardiography, Female, Gene Frequency, Genotype, Humans, Japan, Male, Middle Aged, Obesity blood, Receptors, Adrenergic, beta-3, Triglycerides blood, Tryptophan, Obesity genetics, Point Mutation, Receptors, Adrenergic, beta genetics
- Abstract
To characterize the clinical features associated with the Trp64Arg mutation of the beta3-adrenergic receptor (beta3-AR), the effects of this mutation, in particular the homozygous state (Arg/Arg), on obesity, blood pressure, and plasma lipoproteins were investigated in 2 populations: subjects residing on a small isolated island (group 1; n=746) and patients residing in Tokyo who attend a clinic for metabolic diseases (group 2; n=371). The allelic frequency of the Trp64Arg mutation was 23.4% in group 1 and 18.3% in group 2. No significant difference in the body mass index was observed between subjects with 3 different genotypes in each group. There was a trend that the Arg/Arg had higher systolic blood pressure than the Trp/Trp in both groups, but the differences were not statistically significant. The plasma LDL cholesterol levels were significantly lower in Arg/Arg than in Trp/Trp in men from the group 1 cohort (2.82+/-0.84 versus 3.19+/-0.7 mmol/L, P<0.05). These results suggest that the homozygous Trp64Arg mutation is not a major contributing factor for obesity, but potentially contributed to higher systolic blood pressure and low plasma levels of LDL cholesterol in Japanese men.
- Published
- 1998
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.